Clinical Trials Directory

Trials / Terminated

TerminatedNCT02933671

Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection technique (also called a "nerve block") that numbs the nerves going to the side and front of the upper leg will improve pain control after surgery. The SIFI technique uses a numbing solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This block may affect movement in the leg and make the legs weak. The amount of leg weakness is not known and assessment of this will be included in the study. Many institutions use the SIFI block for patients having total hip replacements, with the hope of providing good pain relief combined with improved mobility after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURESuprainguinal fascia iliaca (SIFI) blockAn ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
PROCEDURESham blockAn ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
DRUGRopivacaineLocal anesthetic (numbing drug)
DRUGSalineSalt water placebo

Timeline

Start date
2017-08-01
Primary completion
2020-03-16
Completion
2020-03-17
First posted
2016-10-14
Last updated
2022-07-19
Results posted
2022-07-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02933671. Inclusion in this directory is not an endorsement.